Shree Ganesh Remedies Ltd.

•

ganeshremedies.comBSE: -NSE: SGRL

Market Cap₹ 878 Cr.

Current Price

High / Low₹ 700 / 477

Stock P/E56.8

Book Value₹ 128

Price to Book3.31

Dividend Yield0.00 %

ROCE14.6 %

ROE11.5 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Promoters have been increasing their shareholding - up 3.5pp over 2 years
Company has a healthy return on capital (ROCE) of 20.7%
Operating margins have improved to 31.7% from 26.2%
Company has delivered good sales growth of 17.4% CAGR over last 5 years
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.23x)

CONS

Receivables are growing faster than sales - a possible quality concern
Recent results are weak - TTM profit is down 23.1% versus prior year
Valuation is stretched - P/E of 56.8 is well above its own 5-year median (30.5)
Though reporting repeated profits, the company pays out little dividend (0.0%)
Expensive relative to growth - PEG of 10.5
Debtor days have increased from 70 to 91

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1933.00	38.34	463791.45	0.83	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9232.00	83.79	245080.59	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	5004.40	87.28	190351.29	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1151.20	25.44	114832.64	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1413.15	33.87	114162.52	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1863.00	92.06	100660.17	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2152.60	17.80	98431.05	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2380.00	48.13	98304.73	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1161.00	30.07	96906.34	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1656.30	25.67	95299.84	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2451.70	38.49	69193.02	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	SGRL	683.95	56.89	878.03	0.00	1.12	-67.49	14.36	-41.79	14.63	23.34

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	27	33	28	37	25	32	27	24	25	30	21	33	14
	20	24	20	20	17	21	17	15	17	21	14	22	14
Operating Profit	7	9	8	17	8	11	10	10	7	10	7	11	3
OPM %	25.75%	27.59%	29.35%	45.38%	32.81%	34.98%	36.64%	40.40%	29.59%	31.73%	31.88%	34.28%	23.34%
Other Income	0	1	1	1	1	0	1	2	1	1	1	1	1
Interest	0	0	0	0	0	0	0	1	1	1	1	1	0
Depreciation	1	1	2	2	2	2	3	2	2	3	3	3	2
	6	9	7	16	6	9	8	9	5	7	4	9	2
Tax %	26.66%	23.81%	35.31%	22.52%	26.50%	25.78%	27.85%	24.83%	25.00%	26.23%	22.36%	28.10%	26.85%
Net Profit	5	7	5	13	5	6	5	7	3	5	3	6	1
	4	5	4	10	4	5	4	5	3	4	2	5	0
Equity Capital	13	12	13	13	13	13	13	13	13	13	13	13	13
Reserves	0	0	0	0	0	0	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	20	27	35	58	49	71	91	126	109	109	99
	16	22	27	47	35	53	68	84	69	74	71
Operating Profit	5	7	10	15	16	21	24	45	43	38	—
OPM %	23	26	28	26	32	30	26	36	40	35	—
Other Income	0	2	1	4	2	4	1	3	4	3	3
Interest	0	0	0	0	0	0	0	1	2	4	3
Depreciation	1	1	1	2	3	3	4	6	10	10	11
	4	6	9	13	13	18	20	38	31	24	21
Tax %	33	28	28	24	25	26	25	26	26	26	26
Net Profit	3	5	6	10	10	13	15	28	23	18	15
EPS	0	0	0	0	10	11	13	22	18	14	—
Dividend Payout %	0	19	18	14	18	4	4	0	0	0	—
Minority Interest	0	0	0	0	0	0	0	0	0	0	0
Share of Associates	0	0	0	0	0	0	0	0	0	0	0
Adjusted EPS	3	4	5	8	8	11	12	22	18	14	—

COMPOUNDED SALES GROWTH

10 Years:: 22%
5 Years:: 17%
3 Years:: 6%

COMPOUNDED PROFIT GROWTH

10 Years:: 32%
5 Years:: 13%
3 Years:: 5%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: 20%
5 Years:: 20%
3 Years:: 19%
Last Year:: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
LIABILITIES	-	-	-	-	-	-	-	-	-	-
Equity Capital	1	9	9	9	10	12	13	13	13	13
	15	20	25	33	40	50	75	109	132	150
	0	2	0	2	0	0	3	1	0	0
Trade Payables	2	2	4	4	6	9	15	8	6	9
	2	3	3	4	4	6	38	47	49	40
Total Liabilities	21	36	41	52	61	77	143	178	200	213
ASSETS	-	-	-	-	-	-	-	-	-	-
	4	6	14	16	19	27	58	81	95	105
Capital Work in Progress	0	0	0	0	2	3	15	17	8	12
	0	4	4	7	3	0	0	5	18	13
	3	4	7	6	13	14	18	25	22	24
	0	0	0	0	0	0	0	20	22	33
Cash & Bank	3	9	1	2	3	4	12	16	10	13
	11	13	15	22	20	29	40	15	24	13
Total Assets	21	36	41	52	61	77	143	178	200	213
Total Debt	0	2	1	2	0	0	33	36	38	31
Net Working Capital	12	22	19	25	28	30	41	51	61	64
Contingent Liabilities	0	0	0	0	0	0	4	5	5	2
Book Value per Share	150.07	31.96	37.70	46.92	49.97	51.28	69.70	95.07	113.10	126.98
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0	-1	-5	4	3	13	17	30	31	24
Cash from Investing	0	-3	-0	-3	-1	-12	-51	-33	-36	-10
Cash from Financing	0	8	-0	-0	-1	-1	39	10	-1	-12
	0	4	-5	1	2	0	5	7	-6	2
Free Cash Flow	-0	-3	-15	-0	-4	1	-30	0	16	-0
OCF / Net Profit	0.00	-0.19	-0.84	0.40	0.34	1.00	1.13	1.08	1.33	1.34
Cumulative 5-Year FCF	0	0	0	0	-22	-21	-48	-33	-17	-13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	24.00	5.22	6.95	10.73	9.75	11.16	12.14	21.89	17.99	13.84
Book Value (₹)	150.07	31.96	37.70	46.92	49.97	51.28	69.70	95.07	113.10	126.98
Dividend per Share (₹)	0.00	1.00	1.25	1.50	1.75	0.50	0.50	0.00	0.00	0.00
Cash EPS (₹)	3.58	4.37	6.01	9.81	10.32	13.84	15.13	26.65	25.44	22.00
PROFITABILITY
Operating Margin %	22.83%	26.31%	28.06%	25.89%	32.07%	30.14%	26.15%	32.32%	35.21%	31.67%
Net Margin %	13.29%	17.19%	17.66%	16.47%	19.87%	18.80%	16.44%	21.74%	20.74%	16.07%
ROE %	17.31%	20.75%	19.95%	25.35%	21.18%	24.02%	20.41%	26.87%	17.28%	11.53%
ROCE %	26.15%	27.68%	27.04%	32.63%	27.51%	32.47%	22.46%	27.83%	19.53%	14.62%
	14.34%	16.52%	16.20%	20.56%	17.29%	19.47%	13.81%	17.51%	12.21%	8.61%
EFFICIENCY
Debtor Days	120	87	80	82	111	81	92	68	70	91
Inventory Days	54	48	56	38	68	67	63	61	77	76
Payable Days	58	52	56	40	83	77	96	75	72	67
	115	83	80	80	96	71	58	54	75	99
FINANCIAL HEALTH
Debt to Equity (x)	0.00x	0.08x	0.02x	0.05x	0.00x	0.00x	0.38x	0.30x	0.26x	0.19x
Interest Coverage (x)	95.30x	64.83x	43.45x	91.53x	192.28x	124.49x	113.31x	64.88x	16.07x	7.74x
	3.74x	4.37x	3.80x	3.60x	3.73x	2.99x	2.63x	2.98x	3.53x	3.39x
GROWTH
Revenue Growth %	27.95%	37.28%	29.54%	65.44%	-16.00%	45.26%	28.15%	37.81%	-13.74%	0.63%
Operating Profit Growth %	99.01%	58.23%	38.14%	52.65%	4.08%	36.50%	12.43%	85.76%	-4.31%	-11.39%
Net Profit Growth %	143.50%	77.66%	33.02%	54.36%	1.35%	37.36%	13.33%	85.17%	-17.85%	-23.05%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	80.38%	-17.82%	-23.05%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	30.48x	39.53x	30.34x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	7.02x	6.29x	3.31x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	19.55x	21.92x	14.62x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	69.33	70.50	72.80	72.80	72.80	72.80	72.80	72.84	72.84
	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.52
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	30.66	29.50	27.19	27.19	27.19	27.19	27.20	27.16	26.64

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for SGRL

Loading news…

🤖

AI Stock Analyst

Shree Ganesh Remedies Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1933.00

38.34

463791.45

0.83

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9232.00

83.79

245080.59

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

5004.40

87.28

190351.29

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1151.20

25.44

114832.64

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1413.15

33.87

114162.52

0.92

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1863.00

92.06

100660.17

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2152.60

17.80

98431.05

0.84

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2380.00

48.13

98304.73

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

DRREDDY

1161.00

30.07

96906.34

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1656.30

25.67

95299.84

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2451.70

38.49

69193.02

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

SGRL

683.95

56.89

878.03

0.00

1.12

-67.49

14.36

-41.79

14.63

23.34

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

OPM %

25.75%

27.59%

29.35%

45.38%

32.81%

34.98%

36.64%

40.40%

29.59%

31.73%

31.88%

34.28%

23.34%

Other Income

Interest

Depreciation

Tax %

26.66%

23.81%

35.31%

22.52%

26.50%

25.78%

27.85%

24.83%

25.00%

26.23%

22.36%

28.10%

26.85%

Net Profit

Equity Capital

Reserves

Promoter Pledge %

0.00%

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

126

109

Operating Profit

—

OPM %

—

Other Income

Interest

Depreciation

Tax %

Net Profit

EPS

—

Dividend Payout %

—

Minority Interest

Share of Associates

Adjusted EPS

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

LIABILITIES

Equity Capital

109

132

150

Trade Payables

Total Liabilities

143

178

200

213

ASSETS

105

Capital Work in Progress

Cash & Bank

Total Assets

143

178

200

213

Total Debt

Net Working Capital

Contingent Liabilities

Book Value per Share

150.07

31.96

37.70

46.92

49.97

51.28

69.70

95.07

113.10

126.98

Face Value

10.00

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-1

-5

Cash from Investing

-3

-0

-3

-1

-12

-51

-33

-36

-10

Cash from Financing

-0

-1

-12

-5

-6

Free Cash Flow

-0

-3

-15

-0

-4

-30

-0

OCF / Net Profit

0.00

-0.19

-0.84

0.40

0.34

1.00

1.13

1.08

1.33

1.34

Cumulative 5-Year FCF

-22

-21

-48

-33

-17

-13

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

24.00

5.22

6.95

10.73

9.75

11.16

12.14

21.89

17.99

13.84

Book Value (₹)

150.07

31.96

37.70

46.92

49.97

51.28

69.70

95.07

113.10

126.98

Dividend per Share (₹)

0.00

1.00

1.25

1.50

1.75

0.50

0.00

Cash EPS (₹)

3.58

4.37

6.01

9.81

10.32

13.84

15.13

26.65

25.44

22.00

PROFITABILITY

Operating Margin %

22.83%

26.31%

28.06%

25.89%

32.07%

30.14%

26.15%

32.32%

35.21%

31.67%

Net Margin %

13.29%

17.19%

17.66%

16.47%

19.87%

18.80%

16.44%

21.74%

20.74%

16.07%

ROE %

17.31%

20.75%

19.95%

25.35%

21.18%

24.02%

20.41%

26.87%

17.28%

11.53%

ROCE %

26.15%

27.68%

27.04%

32.63%

27.51%

32.47%

22.46%

27.83%

19.53%

14.62%

14.34%

16.52%

16.20%

20.56%

17.29%

19.47%

13.81%

17.51%

12.21%

8.61%

EFFICIENCY

Debtor Days

120

111

Inventory Days

Payable Days

115

FINANCIAL HEALTH

Debt to Equity (x)

0.00x

0.08x

0.02x

0.05x

0.00x

0.38x

0.30x

0.26x

0.19x

Interest Coverage (x)

95.30x

64.83x

43.45x

91.53x

192.28x

124.49x

113.31x

64.88x

16.07x

7.74x

3.74x

4.37x

3.80x

3.60x

3.73x

2.99x

2.63x

2.98x

3.53x

3.39x

GROWTH

Revenue Growth %

27.95%

37.28%

29.54%

65.44%

-16.00%

45.26%

28.15%

37.81%

-13.74%

0.63%

Operating Profit Growth %

99.01%

58.23%

38.14%

52.65%

4.08%

36.50%

12.43%

85.76%

-4.31%

-11.39%

Net Profit Growth %

143.50%

77.66%

33.02%

54.36%

1.35%

37.36%

13.33%

85.17%

-17.85%

-23.05%

0.00%

80.38%

-17.82%

-23.05%

VALUATION

P/E (x)

0.00x

30.48x

39.53x

30.34x

P/B (x)

0.00x

7.02x

6.29x

3.31x

Dividend Yield %

0.00%

0.00x

19.55x

21.92x

14.62x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

69.33

70.50

72.80

72.84

0.01

0.00

0.52

Government

0.00

30.66

29.50

27.19

27.20

27.16

26.64

Shree Ganesh Remedies Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Shree Ganesh Remedies Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI